“…The full text of these 43 articles was examined, and an additional 29 studies were excluded. In addition, we included our own case series, resulting in the final inclusion of 15 studies comprising 178 patients with severe treatment-resistant OCD who underwent DB 12 (Table 1). Study designs were heterogeneous, including, among others, randomized control trials, openlabel studies, and case series (Table 1).…”